Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)

NCT03234114 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

3746

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome (ACS)
Non-valvular Atrial Fibrillation (NVAF)

Interventions

DRUG: Triple antithrombotic therapy
DRUG: Dual antithrombotc therapy-1
DRUG: Dual antithrombotc therapy-2

Sponsor

The First Affiliated Hospital with Nanjing Medical University